Genentech

eyeball eye disease eyelash eyes
Biotech

Ollin eyes phase 3 after topping Vabysmo in early-stage trial

Given the findings, the Texas-based biotech is now planning to launch global phase 3 studies this year.
Gabrielle Masson Jan 8, 2026 3:20pm
Ron Park CEO

Addition Tx does the math and emerges from stealth with $100M

Dec 17, 2025 7:45am
red truck in snow globe in snow

Dealmaking flurry continues with Genentech-Caris cancer collab

Dec 16, 2025 11:00am
layoffs employees crossed off

Genentech lets 118 staffers go in another HQ layoff round

Oct 29, 2025 4:55pm
Two fencers spar in a stadium

Eye disease biotech launches with $100M, Roche rival in clinic

Sep 17, 2025 6:30am
IBD UC CD

Genentech pens $420M deal for Omass' preclinical IBD program

Sep 2, 2025 3:00am